Acute myeloid leukemia

Showing 6 of 0 results

• Health disparities in acute myeloid leukemia patients undergoing treatment with tyrosine kinase inhibitor (TKI) therapy targeting FLT3, IDH1, or IDH2

  Blood and Lymphatic Cancer: Targets and Therapy

  • Publication summary
  • Publications
  • Health equity
  • Treatment patterns
  • Acute myeloid leukemia
• Webinar: How breakthrough RWE is powering a new era of blood cancer research
  • Real-world evidence
  • Video
  • Multiple myeloma
  • Diffuse large B-Cell lymphoma
  • Chronic lymphocytic leukemia
  • Acute myeloid leukemia
  • Webinar
  • Artificial intelligence
• Flatiron Health announces research to be presented at the 2025 American Society of Hematology’s Annual Meeting & Exposition
  • Press releases
  • Multiple myeloma
  • Diffuse large B-Cell lymphoma
  • Chronic lymphocytic leukemia
  • Acute myeloid leukemia
• Sociodemographic associations with uptake of novel therapies for acute myeloid leukemia

  Blood Cancer Journal

  • Publication summary
  • Publications
  • Health equity
  • Acute myeloid leukemia
• Low socioeconomic status confers poorer-real-world overall survival for patients with acute myeloid leukemia treated in the modern era

  2023 ASH Annual Meeting and Exposition

  • Publication summary
  • Publications
  • Health equity
  • Acute myeloid leukemia
• Development of a derived induction failure and relapse variable for acute myeloid leukemia using real-world data from an electronic health record-derived database

  Value in Health

  • Publication summary
  • Publications
  • Methodology
  • Acute myeloid leukemia